Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Erlander

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2017
Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral PopulationJack Cuzick, Louise Cadman, Amar S Ahmad, et al.
Cancer Discovery|April 7, 2016
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination TherapySamuel J Klempner, Bruce Gershenhorn, Phu Tran, et al.
Breast Cancer Research and Treatment|April 27, 2016
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14Judith-Anne W Chapman, Dennis C Sgroi, Paul E Goss, et al.
Breast Cancer Research : BCR|January 6, 2016
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 studyDennis C Sgroi, Judy-Anne W Chapman, T Badovinac-Crnjevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2003
Gene expression profiles of human breast cancer progressionXiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, et al.
Cancer Research|April 16, 2009
Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitorsUltan McDermott, Rachel Y Ames, A John Iafrate, et al.
Cancer Research|November 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor SignalingJesse C Patterson, Andreas Varkaris, Peter J P Croucher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and PlasmaKaren L Reckamp, Vladislava O Melnikova, Chris Karlovich, et al.
Journal of the National Cancer Institute|July 2, 2013
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarkerDennis C Sgroi, Erin Carney, Elizabeth Zarrella, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2017
Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral PopulationJack Cuzick, Louise Cadman, Amar S Ahmad, et al.
Cancer Discovery|April 7, 2016
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination TherapySamuel J Klempner, Bruce Gershenhorn, Phu Tran, et al.
Breast Cancer Research and Treatment|April 27, 2016
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14Judith-Anne W Chapman, Dennis C Sgroi, Paul E Goss, et al.
Breast Cancer Research : BCR|January 6, 2016
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 studyDennis C Sgroi, Judy-Anne W Chapman, T Badovinac-Crnjevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2003
Gene expression profiles of human breast cancer progressionXiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, et al.
Cancer Research|April 16, 2009
Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitorsUltan McDermott, Rachel Y Ames, A John Iafrate, et al.
Cancer Research|November 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor SignalingJesse C Patterson, Andreas Varkaris, Peter J P Croucher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and PlasmaKaren L Reckamp, Vladislava O Melnikova, Chris Karlovich, et al.
Journal of the National Cancer Institute|July 2, 2013
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarkerDennis C Sgroi, Erin Carney, Elizabeth Zarrella, et al.
Pageof 5